Latest News
Needham analyst Bernie McTernan maintained a Buy rating on DraftKings Inc. (NASDAQ:DKNG) and reiterated the $65 price forecast following the first quarter results reported on Thursday.
Via Benzinga · May 9, 2025
The CEO dismissed the impact of Trump tariffs, noting that the company produces a major portion of its goods in the U.S.
Via Stocktwits · May 9, 2025
Via Benzinga · May 9, 2025
U.S. corn export sales week ending May 1st totaled 65 Mil Bu, a full 57 Mil above the pace needed to meet USDA's annual forecast.
Via Talk Markets · May 9, 2025
Via The Motley Fool · May 9, 2025
Wall Street traded slightly lower by midday Friday, as investors adopted a wait-and-see stance ahead of a potential trade breakthrough, with high-stakes negotiations between U.S. officials—led by Treasury Secretary Scott Bessent—and Chinese authorities set to unfold over the weekend.
Via Benzinga · May 9, 2025
EchoStar Corporation (NASDAQ: SATS) reported a loss of 71 cents per share, with quarterly sales of $3.87 billion. SATS stock has gained 56% in the past year.
Via Benzinga · May 9, 2025
Via Benzinga · May 9, 2025
U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states and assets of around $680 billion.
Via Talk Markets · May 9, 2025
The oil market is starting to finally turn around as President Trump’s trade deals may start to come fast and furious.
Via Talk Markets · May 9, 2025
Via Benzinga · May 9, 2025
Via Benzinga · May 9, 2025
Google’s back-to-back discrimination cases have pushed Alphabet’s settlement total to $78 million in just two months.
Via Stocktwits · May 9, 2025
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
Via Benzinga · May 9, 2025
Trade talks are in focus, ahead of negotiations between U.S. and Chinese officials, which will begin in Switzerland this weekend.
Via Talk Markets · May 9, 2025
Lyft stock rises on $1.45B revenue, $750M buyback plan. Needham reiterates hold, Goldman Sachs upgrades to buy with PT of $20. Strong growth despite competition.
Via Benzinga · May 9, 2025
JPMorgan lowered its price target on Coinbase to $215 from $276 and kept a ‘Neutral’ rating on the shares, as per TheFly.
Via Stocktwits · May 9, 2025
Tax preparation company H&R Block (NYSE:HRB) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 4.2% year on year to $2.28 billion. The company expects the full year’s revenue to be around $3.72 billion, close to analysts’ estimates. Its non-GAAP profit of $5.38 per share was 4.1% above analysts’ consensus estimates.
Via StockStory · May 9, 2025
Coinbase Derivatives LLC (NASDAQ:COIN) has launched 24/7 trading for Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) futures, making it t
Via Benzinga · May 9, 2025
TTD stock soars as company surpasses Q1 expectations and raises Q2 revenue outlook. Analysts also raise price forecasts and outlook for company.
Via Benzinga · May 9, 2025
Via Benzinga · May 9, 2025
Via Benzinga · May 9, 2025
The analysis aims to provide valuable insights into market trends and potential opportunities.
Via Talk Markets · May 9, 2025
Internet security and content delivery network Cloudflare (NYSE:NET) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 26.5% year on year to $479.1 million. The company expects next quarter’s revenue to be around $500.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.16 per share was in line with analysts’ consensus estimates.
Via StockStory · May 9, 2025
Analysts maintain Buy rating & $25 price forecast for Hut 8 Corp. despite weak Q1 results. Shift to American BTC mining & HPC pipeline updates cited.
Via Benzinga · May 9, 2025
Shares of Clover Health have surged 8.7% this week. The company reported Q1 results that highlighted rising profitability.
Via Benzinga · May 9, 2025
Via The Motley Fool · May 9, 2025
Via Benzinga · May 9, 2025
Local governments sue the Trump administration over the abrupt termination of $11 billion in CDC pandemic preparedness grants, alleging violations of federal law and the Constitution.
Via Benzinga · May 9, 2025
Corvus announced new interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis.
Via Stocktwits · May 9, 2025
MARA Holdings, Inc. (NASDAQ:MARA) and CleanSpark, Inc. (NASDAQ:CLSK) shares are trading volatile on Friday amid worse-than-expected financial results on Thursday after t
Via Benzinga · May 9, 2025
Apple Inc developing new chips for smart glasses, intensifying rivalry with Meta's Ray-Ban glasses. Chips to control glasses' cameras & release by 2026-27.
Via Benzinga · May 9, 2025